Hepatitis C virus genotype 4 and response to combination therapy with interferon-α2b plus ribavirin

被引：4
|
作者：
Bruno, S [1 ]
Crosignani, A
Pinzello, GB
机构：
[1] S Paolo Univ Milan, I-20142 Milan, Italy
[2] Crespi Niguarda Hosp Milan, Liver Unit, I-20100 Milan, Italy
来源：
ANNALS OF INTERNAL MEDICINE | 2000年 / 133卷 / 11期
关键词：
D O I：
10.7326/0003-4819-133-11-200012050-00025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：922 / 923
页数：2
相关论文
共 50 条
  • [41] Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection
    Pawlotsky, Jean-Michel
    Flisiak, Robert
    Sarin, Shiv K.
    Rasenack, Jens
    Piratvisuth, Teerha
    Chuang, Wan-Long
    Peng, Cheng-Yuan
    Foster, Graham R.
    Shah, Samir
    Wedemeyer, Heiner
    Hezode, Christophe
    Zhang, Wei
    Wong, Kelly A.
    Li, Bin
    Avila, Claudio
    Naoumov, Nikolai V.
    HEPATOLOGY, 2015, 62 (04) : 1013 - 1023
  • [42] Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients
    Lee, Seok
    Kim, In Hee
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    Lee, Chang Seop
    Choi, Chang Soo
    Cho, Eun Young
    Kim, Haak Cheoul
    INTERVIROLOGY, 2010, 53 (03) : 146 - 153
  • [43] Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study
    Giulia Malaguarnera
    Gaetano Bertino
    Carmela Greco
    Caterina Gagliano
    Massimo Motta
    Giuseppe Chisari
    Venerando Rapisarda
    Giuseppe Nunnari
    Michele Vecchio
    Filippo Drago
    Michele Malaguarnera
    Translational Medicine Communications, 2 (1)
  • [44] Repeated episodes of fixed eruption 3 months after discontinuing pegylated interferon-α-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection
    Sato, M.
    Sueki, H.
    Iijima, M.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (08) : E814 - E817
  • [45] Pioglitazone improves virological response to peginterferon α-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance
    Khattab, Mahmoud
    Emad, Mohammed
    Abdelaleem, Asharf
    Eslam, Mohammed
    Atef, Rabab
    Shaker, Yehia
    Hamdy, Lamia
    LIVER INTERNATIONAL, 2010, 30 (03) : 447 - 454
  • [46] Interferon alfa 2b and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon therapy
    Galica, M
    Alhajjar, B
    Salen, G
    Dyrszka, H
    Sanghavi, B
    Eskreis, D
    HEPATOLOGY, 1998, 28 (04) : 709A - 709A
  • [47] High-dose interferon-α2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-α monotherapy
    Hass, Holger G.
    Kreysel, Christian
    Fischinger, Johannes
    Menzel, Josef
    Kaiser, Stephan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (34) : 5342 - 5346
  • [48] Synergistic antiviral activity of interferon-α2b and ribavirin against a surrogate virus of hepatitis C.
    Lau, J
    Ingravallo, P
    Skelton, A
    Hajian, G
    Zhong, W
    Hong, Z
    HEPATOLOGY, 1999, 30 (04) : 190A - 190A
  • [49] New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection
    Abe, Hiroshi
    Aida, Yuta
    Ishiguro, Haruya
    Yoshizawa, Kai
    Seki, Nobuyoshi
    Miyazaki, Tamihiro
    Itagaki, Munenori
    Sutoh, Satoshi
    Ika, Makiko
    Kato, Keizo
    Shimada, Noritomo
    Tsubota, Akihito
    Aizawa, Yoshio
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (09) : 1523 - 1533
  • [50] Sustained response to interferon-α or to interferon-α plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia
    Calleja, JL
    Albillos, A
    Moreno-Otero, R
    Rossi, I
    Cacho, G
    Domper, F
    Yebra, M
    Escartín, P
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (09) : 1179 - 1186
12345